Your browser doesn't support javascript.
loading
Combined Next-generation Sequencing and Flow Cytometry Analysis for an Anti-PD-L1 Partial Responder over Time: An Exploration of Mechanisms of PD-L1 Activity and Resistance in Bladder Cancer.
Kates, Max; Nirschl, Thomas R; Baras, Alex S; Sopko, Nikolai A; Hahn, Noah M; Su, Xiaoping; Zhang, Jiexin; Kochel, Christina M; Choi, Woonyoung; McConkey, David J; Drake, Charles G; Bivalacqua, Trinity J.
Afiliação
  • Kates M; Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA; Sydney Kimmel Comprehensive Cancer Center, Johns Hopkins Medical Institutions, Baltimore, MD, USA; Greenberg Bladder Cancer Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA. Electronic address: mkate
  • Nirschl TR; Sydney Kimmel Comprehensive Cancer Center, Johns Hopkins Medical Institutions, Baltimore, MD, USA.
  • Baras AS; Sydney Kimmel Comprehensive Cancer Center, Johns Hopkins Medical Institutions, Baltimore, MD, USA; Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD, USA.
  • Sopko NA; Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA.
  • Hahn NM; Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA; Sydney Kimmel Comprehensive Cancer Center, Johns Hopkins Medical Institutions, Baltimore, MD, USA; Greenberg Bladder Cancer Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA.
  • Su X; Department of Bioinformatics and Computational Biology, MD Anderson Cancer Center, Houston, TX, USA.
  • Zhang J; Department of Bioinformatics and Computational Biology, MD Anderson Cancer Center, Houston, TX, USA.
  • Kochel CM; Sydney Kimmel Comprehensive Cancer Center, Johns Hopkins Medical Institutions, Baltimore, MD, USA.
  • Choi W; Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA; Greenberg Bladder Cancer Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA.
  • McConkey DJ; Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA; Greenberg Bladder Cancer Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA.
  • Drake CG; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY, USA.
  • Bivalacqua TJ; Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA; Sydney Kimmel Comprehensive Cancer Center, Johns Hopkins Medical Institutions, Baltimore, MD, USA; Greenberg Bladder Cancer Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA.
Eur Urol Oncol ; 4(1): 117-120, 2021 02.
Article em En | MEDLINE | ID: mdl-31411999
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição / Inibidores de Checkpoint Imunológico Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição / Inibidores de Checkpoint Imunológico Idioma: En Ano de publicação: 2021 Tipo de documento: Article